<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03701542</url>
  </required_header>
  <id_info>
    <org_study_id>0003</org_study_id>
    <nct_id>NCT03701542</nct_id>
  </id_info>
  <brief_title>The Application of M-charts and Microperimetry for the Assessment of Visual Function in Patients After Vitrectomy Due to the Full Thickness Macular Hole.</brief_title>
  <official_title>The Application of M-charts and Microperimetry for the Assessment of Visual Function in Patients After Vitrectomy Due to the Full Thickness Macular Hole.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Lublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Lublin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To examine the relationship between morphological and functional results in eyes after
      vitrectomy due to the full thickness macular hole (FTMH).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The best-corrected visual acuity (BCVA)</measure>
    <time_frame>1 to 6 months</time_frame>
    <description>Acuity is a measure of visual performance. The eye exam seeks to find the prescription that will provide the best corrected visual performance achievable</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Amsler test</measure>
    <time_frame>1 to 6 months</time_frame>
    <description>The Amsler grid, consisting of evenly spaced horizontal and vertical lines, has been widely used since 1947 to test the metamorphopsia.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Central retinal thickness</measure>
    <time_frame>1 to 6 months</time_frame>
    <description>Quantitative thickness measurements derived from the &quot;fast macular scan&quot; algorithm report retinal thickness at several locations including the center point, central subfield, and 4 inner and 4 outer zones of the macula.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Retinal sensitivity</measure>
    <time_frame>1 to 6 months</time_frame>
    <description>Microperimetry is a procedure to assess retinal sensitivity while fundus is directly examined; it enables exact correlation between macular pathology and corresponding functional abnormality. It is a psychophysical method which is rapid, safe and non-invasive.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">22</enrollment>
  <condition>Macular Holes</condition>
  <condition>Microperymetry</condition>
  <condition>Vitrectomy</condition>
  <condition>M-charts</condition>
  <arm_group>
    <arm_group_label>Group of 22 patients</arm_group_label>
    <description>Group of 22 patients who underwent vitrectomy due to macular hole</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Microperymetry</intervention_name>
    <description>Microperimetry is a procedure to assess retinal sensitivity while fundus is directly examined; it enables exact correlation between macular pathology and corresponding functional abnormality.</description>
    <arm_group_label>Group of 22 patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>M-charts</intervention_name>
    <description>The M-chart (Inami Co., Tokyo, Japan) is a diagnostic tool developed by Matsumoto to quantify the degree of metamorphopsia in patients with macular diseases.</description>
    <arm_group_label>Group of 22 patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        22 patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        The diagnosed full thickness macular hole and psuedophakia.

        Exclusion Criteria:

        macular pseudohole, non-full thickness macular hole, retinal detachment, other ocular
        comorbidities.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 8, 2018</study_first_submitted>
  <study_first_submitted_qc>October 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2018</study_first_posted>
  <last_update_submitted>October 8, 2018</last_update_submitted>
  <last_update_submitted_qc>October 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>macular hole</keyword>
  <keyword>microperymetry</keyword>
  <keyword>vitrectomy</keyword>
  <keyword>m-charts</keyword>
  <keyword>metamorphopsia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All data will be available in brief.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

